Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
enVVeno Medical Corp (HJLI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/02/2022 |
4
| Jenusaitis Matthew (Director) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Granted 8,403 options
@ $6.7, valued at
$56.3k
|
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2022 |
4
| Gray Robert (Director) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Exercised 1,041 restricted stock units
@ $0 |
|
| 09/16/2022 |
4
| Jenusaitis Matthew (Director) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Exercised 1,041 restricted stock units
@ $0 |
|
| 08/18/2022 |
4
| Duhay Francis (Director) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Bought 7,751 shares
@ $6.14, valued at
$47.6k
|
|
| 07/01/2022 |
4
| Shrivastava Sanjay (Director) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Bought 1,000 shares
@ $3.85, valued at
$3.9k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Glickman Marc H. (SVP & Chief Medical Officer) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Granted 100,000 shares
@ $0
Granted 265,700 options
@ $6.7, valued at
$1.8M
|
|
| 12/02/2021 |
4
| Glynn Craig (CFO) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Granted 50,000 shares
@ $0
Granted 125,925 options
@ $6.7, valued at
$843.7k
|
|
| 12/02/2021 |
4
| Gray Robert (Director) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Granted 7,211 options
@ $6.7, valued at
$48.3k
|
|
| 12/02/2021 |
4
| Duhay Francis (Director) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Granted 7,211 options
@ $6.7, valued at
$48.3k
|
|
| 12/02/2021 |
4
| Jenusaitis Matthew (Director) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Granted 7,211 options
@ $6.7, valued at
$48.3k
|
|
| 12/02/2021 |
4
| Shrivastava Sanjay (Director) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Granted 7,211 options
@ $6.7, valued at
$48.3k
|
|
| 11/19/2021 |
4
| BERMAN ROBERT ANDREW (CEO) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Bought 2,000 shares
@ $7.43, valued at
$14.9k
|
|
| 11/18/2021 |
4
| Shrivastava Sanjay (Director) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Exercised 388 restricted stock units
@ $0 |
|
| 11/18/2021 |
4
| BERMAN ROBERT ANDREW (CEO) has filed a Form 4 on enVVeno Medical Corp|
Txns:
| Bought 2,000 shares
@ $7.87, valued at
$15.7k
|
|
| 09/15/2021 |
4
| Jenusaitis Matthew (Director) has filed a Form 4 on Hancock Jaffe Laboratories, Inc.|
Txns:
| Exercised 1,042 restricted stock units
@ $0 |
|
| 09/15/2021 |
4
| Gray Robert (Director) has filed a Form 4 on Hancock Jaffe Laboratories, Inc.|
Txns:
| Exercised 1,042 restricted stock units
@ $0 |
|
| 08/27/2021 |
4
| Jenusaitis Matthew (Director) has filed a Form 4 on Hancock Jaffe Laboratories, Inc.|
Txns:
| Bought 1,300 shares
@ $7.7, valued at
$10k
|
|
| 06/21/2021 |
4
| Gray Robert (Director) has filed a Form 4 on Hancock Jaffe Laboratories, Inc.|
Txns:
| Bought 2,000 shares
@ $6.25, valued at
$12.5k
|
|
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Jenusaitis Matthew (Director) has filed a Form 4 on Hancock Jaffe Laboratories, Inc.|
Txns:
| Granted 5,673 options to buy
@ $8.2, valued at
$46.5k
|
|
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2020 |
4
| Jenusaitis Matthew (Director) has filed a Form 4 on Hancock Jaffe Laboratories, Inc.|
Txns:
| Granted 62,500 shares
@ $0
Granted 78,125 restricted stock units
@ $0
Granted 60,000 options to buy
@ $2, valued at
$120k
Granted 100,000 options to buy
@ $0.4, valued at
$40k
|
|
|
|
|